{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:04:49Z","timestamp":1773425089143,"version":"3.50.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022893","name":"Faculty of Associated Medical Sciences, Chiang Mai University","doi-asserted-by":"publisher","award":["AMS Research Grant 2024"],"award-info":[{"award-number":["AMS Research Grant 2024"]}],"id":[{"id":"10.13039\/100022893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","award":["CMU Proactive Researcher program (Grant number 1230\/2567)"],"award-info":[{"award-number":["CMU Proactive Researcher program (Grant number 1230\/2567)"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Neutralizing anti-interferon gamma autoantibodies (nAIGAs) play a pivotal role in the pathogenesis of adult-onset immunodeficiency (AOID), predisposing affected individuals to severe opportunistic infections. Current detection of nAIGAs relies on cell-based assays requiring flow cytometric analysis, which limits routine clinical settings. Notably, nAIGAs recognizing the B27 epitope of interferon gamma (IFN-\u03b3) exhibit strong neutralizing activity, underscoring the need for practical, epitope-specific detection methods for routine diagnostic. This study aimed to develop and validate a competitive enzyme-linked immunosorbent assay (cELISA) as a surrogate assay for detecting B27 epitope-targeting nAIGAs in plasma samples from patients with AOID. Plasma samples from patients with AOID (n\u2009=\u200940) and healthy controls (n\u2009=\u200940) were initially screened for AIGAs using an indirect ELISA. Neutralizing activity was confirmed using a cell-based assay measuring MHC class II expression on IFN-\u03b3-stimulated THP-1 cells. The cELISA was subsequently developed and optimized to detect nAIGAs specific to the B27 epitope. ROC curve analysis was performed to assess the diagnostic performance of the assay. All AOID samples with detectable levels of AIGAs showed percentage inhibition above the cut-off in the cell-based assay, confirming the neutralizing activity of AIGAs. The developed cELISA detected nAIGAs in 36 of 40 AOID samples, with no false-positive results observed among healthy controls. ROC curve analysis indicated excellent diagnostic performance, yielding an area under curves (AUC) of 0.9684. Taken together, our findings indicate that the developed cELISA serves as a surrogate assay for detecting nAIGAs targeting the B27 epitope of IFN-\u03b3. This assay represents a practical and scalable tool for AOID screening and may facilitate broader applications in clinical diagnostics.<\/jats:p>","DOI":"10.1371\/journal.pone.0344451","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:29:55Z","timestamp":1773422995000},"page":"e0344451","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a monoclonal antibody-based competitive ELISA as a surrogate assay for detecting neutralizing anti-interferon gamma autoantibodies in adult-onset immunodeficiency"],"prefix":"10.1371","volume":"21","author":[{"given":"Kanokporn","family":"Sornsuwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanyarat","family":"Thongheang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkarat","family":"Wongsawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatchai","family":"Tayapiwatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9169-7285","authenticated-orcid":true,"given":"Umpa","family":"Yasamut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"7","key":"pone.0344451.ref001","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"SG Tangye","year":"2022","journal-title":"J Clin Immunol"},{"issue":"9","key":"pone.0344451.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand","volume":"8","author":"P Wongkulab","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"pone.0344451.ref003","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"SK Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0344451.ref004","doi-asserted-by":"crossref","first-page":"1051673","DOI":"10.3389\/fimmu.2022.1051673","article-title":"Pathogen spectrum and immunotherapy in patients with anti-IFN-\u03b3 autoantibodies: A multicenter retrospective study and systematic review","volume":"13","author":"Y Qiu","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"pone.0344451.ref005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s10875-023-01537-0","article-title":"Characteristics and outcomes of anti-interferon gamma antibody-associated adult onset immunodeficiency","volume":"43","author":"B Zhang","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"pone.0344451.ref006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10875-025-01885-z","article-title":"Deepening understanding of the clinical features and diagnostic approaches to anti-interferon-gamma autoantibody associated adult-onset immunodeficiency in the last 20 years: A Case report and literature review","volume":"45","author":"L Zhao","year":"2025","journal-title":"J Clin Immunol"},{"issue":"12","key":"pone.0344451.ref007","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.jiph.2025.102952","article-title":"Clinical characteristics analysis of anti-interferon-\u03b3 autoantibodies-associated adult-onset immunodeficiency with mycobacterium tuberculosis infection","volume":"18","author":"X Huang","year":"2025","journal-title":"J Infect Public Health"},{"issue":"7","key":"pone.0344451.ref008","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"SY Patel","year":"2005","journal-title":"J Immunol"},{"key":"pone.0344451.ref009","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2019.01905","article-title":"Neutralizing activity of anti-interferon-\u03b3 autoantibodies in adult-onset immunodeficiency is associated with their binding domains","volume":"10","author":"U Yasamut","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0344451.ref010","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1038\/s41598-019-41952-1","article-title":"Functional neutralization of anti-IFN-\u03b3 autoantibody in patients with nontuberculous mycobacteria infection","volume":"9","author":"DI Krisnawati","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"pone.0344451.ref011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1535370220981579","article-title":"Minireview: Insights into anti-interferon-\u03b3 autoantibodies","volume":"246","author":"K Chawansuntati","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"pone.0344451.ref012","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1038\/s41598-020-65933-x","article-title":"Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA","volume":"10","author":"A Nithichanon","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0344451.ref013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","article-title":"Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients","volume":"20","author":"K Shima","year":"2014","journal-title":"J Infect Chemother"},{"issue":"8","key":"pone.0344451.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf478","article-title":"Detection of Anti-IFN\u03b3 autoantibodies from dried blood spots","volume":"12","author":"AJ Harris","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"pone.0344451.ref015","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/trf.16652","article-title":"A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma","volume":"61","author":"E Wouters","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"pone.0344451.ref016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12917-020-2237-6","article-title":"A neutralizing monoclonal antibody-based competitive ELISA for classical swine fever C-strain post-vaccination monitoring","volume":"16","author":"L Wang","year":"2020","journal-title":"BMC Vet Res"},{"issue":"1","key":"pone.0344451.ref017","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/s41598-022-11774-9","article-title":"Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency","volume":"12","author":"U Yasamut","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0344451.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-\u03b3 autoantibodies","volume":"14","author":"N Angkasekwinai","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"pone.0344451.ref019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0161-5890(89)90015-1","article-title":"Epitope mapping of recombinant human gamma interferon using monoclonal antibodies","volume":"26","author":"C Favre","year":"1989","journal-title":"Mol Immunol"},{"key":"pone.0344451.ref020","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.3389\/bjbs.2024.12339","article-title":"The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection","volume":"81","author":"NE Timbrell","year":"2024","journal-title":"Br J Biomed Sci"},{"issue":"9","key":"pone.0344451.ref021","article-title":"Pathogenic autoantibodies to IFN-\u03b3 act through the impedance of receptor assembly and Fc-mediated response","volume":"219","author":"H-P Shih","year":"2022","journal-title":"J Exp Med"},{"issue":"9","key":"pone.0344451.ref022","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-\u03b3 autoantibodies in patients with mycobacterial disease","volume":"22","author":"C-H Lin","year":"2016","journal-title":"Nat Med"},{"issue":"3","key":"pone.0344451.ref023","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cyto.2012.06.257","article-title":"P156 Investigating the novel mechanism of action for NI-0501, a human interferon gamma monoclonal antibody","volume":"59","author":"E Hatterer","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"pone.0344451.ref024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antib5010003","article-title":"Anticytokine autoantibodies: Association with infection and immune dysregulation","volume":"5","author":"V Knight","year":"2016","journal-title":"Antibodies (basel)"},{"issue":"1","key":"pone.0344451.ref025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10067-023-06758-7","article-title":"Neutralizing anti-IFN-\u03b3 IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection","volume":"43","author":"L Chen","year":"2024","journal-title":"Clin Rheumatol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:29:59Z","timestamp":1773422999000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344451"}},"subtitle":[],"editor":[{"given":"Suresh","family":"Pallikkuth","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344451","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}